Shareholder Notice: Brodsky & Smith Announces An Investigation Of Summit Materials (Sum)


(MENAFN- Newsfile Corp) SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Summit Materials (SUM)

Bala Cynwyd, Pennsylvania--(Newsfile Corp. - September 7, 2023) - Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Summit Materials ("Summit" or the "Company") (NYSE: SUM) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the merger of the Company and Argos North America Corp. ("Argos"). Under the terms of the merger agreement, the companies will combine in a cash and stock transaction valued at $3.2 billion. Post close, Argos will have a 31% interest in Summit.

The investigation concerns whether the Summit Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution of Summit shareholders in the combined company.

If you own shares of Summit stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman by email at , visit , or call toll free 855-576-4847.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numercourts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.


Shareholder Notice: Brodsky & Smith Announces An Investigation Of Summit Materials (Sum) Image

To view the source version of this press release, please visit

MENAFN07092023004218003983ID1107029559


Newsfile Corp

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.